Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation
Sweden
14796317.7
Filed on 2014-10-02
14796317.7
Filed on 2014-10-02
Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation
Spain
14796317.7
Filed on 2014-10-02
14796317.7
Filed on 2014-10-02
Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation
Norway
14796317.7
Filed on 2014-10-02
14796317.7
Filed on 2014-10-02
Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation
The Netherlands
14796317.7
Filed on 2014-10-02
14796317.7
Filed on 2014-10-02
Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation
Italy
14796317.7
Filed on 2014-10-02
14796317.7
Filed on 2014-10-02
Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation
Germany
14796317.7
Filed on 2014-10-02
14796317.7
Filed on 2014-10-02
Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation
France
14796317.7
Filed on 2014-10-02
14796317.7
Filed on 2014-10-02
Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation
Denmark
14796317.7
Filed on 2014-10-02
14796317.7
Filed on 2014-10-02
Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation
Belgium
14796317.7
Filed on 2014-10-02
14796317.7
Filed on 2014-10-02
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION
US Application 17/799,163
Filed on 2022-08-11
Filed on 2022-08-11